Interaction between the UCP2 -866 G>A polymorphism, diabetes, and β-blocker use among patients with acute coronary syndromes

Pharmacogenetics and Genomics

Volumn 20, Issue 4, 2010, Pages 231-238

  Beitelshees, Amber L ^a   Finck, Brian N ^b   Leone, Teresa C ^c,e   Cresci, Sharon ^c   Wu, Jun ^d   Province, Michael A ^d   Fabbrini, Elisa ^b,f   Kirk, Erik ^b   Zineh, Issam ^g   Klein, Samuel ^b   Spertus, John A ^h   Kelly, Daniel R ^c,e  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Center for Human Nutrition   (Italy)

^c Cardiovascular Research Unit   (Italy)

^d Burnham Institute for Medical Research at Lake Nona   (Italy)

^e Catholic University School of Medicine   (Italy)

^f IRCCS SAN RAFFAELE PISANA   (Italy)

^g UNIVERSITY OF FLORIDA HEALTH   (United States)

^h UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Acute coronary syndromes; Gene environment interaction; Pharmacogenetics; Type 2 diabetes

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; UNCOUPLING PROTEIN 2;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; FEMALE; GENETIC TRANSCRIPTION; HOSPITAL READMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; OBESITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; AGED; CELL LINE; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; HUMANS; ION CHANNELS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; OBESITY; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINANT PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 77950654523     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283377abc     Document Type: Article

References (24)

1. Smith NL, Maynard C. The burden of diabetes-associated cardiovascular hospitalizations in Veterans Administration (VA) and non-VA medical facilities. Diabetes Care 2004; 27 (Suppl 2): B27-B32. (Pubitemid 38569261)
2. Cubbon RM, Wheatcroft SB, Grant PJ, Gale CP, Barth JH, Sapsford RJ, et al. Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur Heart J 2007; 28: 540-545.
3. Ishizawa M, Mizushige K, Noma T, Namba T, Guo P, Murakami K, et al. An antioxidant treatment potentially protects myocardial energy metabolism by regulating uncoupling protein 2 expression in a chronic beta-adrenergic stimulation rat model. Life Sci 2006; 78: 2974-2982.
4. Nagase I, Yoshida T, Salto M. Up-regulatlon of uncoupling proteins by betaadrenergic stimulation in L6 myotubes. FEBS Lett 2001; 494: 175-180. (Pubitemid 32322678)
5. Affourtit C, Brand MD. On the role of uncoupling protein-2 in pancreatic beta cells. Biochim Biophys Acta 2008; 1777: 973-979.
6. O'Rahilly S. Uncoupling protein 2: adiposity angel and diabetes devil? Nat Med 2001; 7: 770-772. (Pubitemid 32691624)
7. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999; 98: 115-124. (Pubitemid 29331201)
8. Cheurfa N, Dubois-Laforgue D, Ferrarezi DA, Reis AF, Brenner GM, Bouche C, et al. The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men. Diabetes 2008; 57: 1063-1068.
9. Dhamrait SS, Stephens JW, Cooper JA, Acharya J, Mani AR, Moore K, et al. Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. Eur Heart J 2004; 25: 468-475. (Pubitemid 38524271)
10. Esterbauer H, Schneitier C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F, et al. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 2001; 28: 178-183.
11. Gable DR, Stephens JW, Cooper JA, Miller GJ, Humphries SE. Variation in the UCP2-UCP3 gene cluster predicts the development of type 2 diabetes in healthy middle-aged men. Diabetes 2006; 55: 1604-11511
12. KremplerF,EsterbauerH,WeitgasserR,EbenbichlerC,PatschJR,MillerK,etal. AfunctionalpolymorphisminthepromoterofUCP2 enhancesobesityriskbutreducestype2diabetesriskinobesemiddle-agedhumans. Diabetes2002;51:3331-3335.(Pubitemid35246982)
13. Oberkofler H, lglseder B, Klein K, Unger J, Haltmayer M, Krempler F, et al. Associations of the UCP2 gene locus with asymptomatic carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vase Biol 2005; 25: 604-610.
14. WangH,ChuWS,LuT,HasstedtSJ,KernPA,ElbeinSC.Uncouplingprotein- 2polymorphismsintype2diabetes,obesity,andinsulinsecretion. AmJPhysiolEndocrinolMetab2004;286:E1-E7.(Pubitemid38036602)
15. Joseph JW, Koshkin V, Saleh MC, Sivitz Wl, Zhang CY, Lowell BB, et al. Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression. J Biol Chem 2004; 279: 51049-51056. (Pubitemid 40017846)
16. Gaussin V, Tomlinson JE, Depre C, Engelhardt S, Antos CL, Takagi G, et al. Common genomic response in different mouse models of beta-adrenergicinduced cardiomyopathy. Circulation 2003; 108: 2926-2933. (Pubitemid 37517822)
17. Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. JAMA 2005; 294: 1626-1633. (Pubitemid 41362690)
18. Braunwald E. Unstable angina. A classification. Circulation 1989; 80: 410-414.
19. Du K, Asahara H, Jhala US, Wagner BL, Montminy M. Characterization of a CREB gain-of-functlon mutant with constitutive transcriptional activity in vivo. Mol Cell Biol 2000; 20: 4320-4327. (Pubitemid 30346626)
20. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009; 106: 15430-15435.
21. Kirk E, Reeds DN, Finck BN, Mayurranjan SM, Patterson BW, Klein S. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 2009; 136: 1552-1560.
22. Maneia G, Grassi G, Zanchetti A. New-onset diabetes and antihypertensive drugs. J Hypertens 2006; 24: 3-10.
23. Sarafidis PA, Bakris GL. Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control. QJM 2006; 99: 431-436. (Pubitemid 44304843)
24. Sasahara M, Nlshi M, Kawashlma H, Ueda K, Sakagashira S, Furuta H, et al. Uncoupling protein 2 promoter polymorphism -866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients. Diabetes 2004; 53: 482-485. (Pubitemid 38174566)